Modifi Bio
Vishwas Paralkar is a Member of the Scientific Advisory Board at Modifi Bio, where Vishwas currently works. Prior to this, Vishwas served as the Chief Scientific Officer at Cybrexa Therapeutics and Karos Pharmaceuticals, where Vishwas had a successful exit after the sale of the company. Vishwas also held various positions at Pfizer Pharmaceuticals and SVP Pfizer before that. Paralkar has a PhD in Cell Biology/Biochemistry from Howard University.
This person is not in any offices
Modifi Bio
Modifi Biosciences is a leader in direct DNA modification developing novel cancer therapeutics.